Dengue NS1 Rapid Test Device

Call For Pricing.

Model Number: NH-41578

Brand: Niche Healthcare

The Dengue NS1 Rapid Test Device is a lateral flow chromatographic immunoassay for the qualitative detection of antigens to Dengue viruses in human Whole Blood/Serum/Plasma. It provides an aid in the diagnosis of infection with Dengue viruses.

 

Description

Catalog No. DEN-4012 Format Device
Specimen Whole Blood/Serum/Plasma Certificate CE
Reading Time 15 minutes Test/Kit 40
Storage Temperature 4-30°C Shelf Life 2 Years
Sensitivity >99.9% Specificity >99.9%
Accuracy >99.9% Composition Test device, dropper, desiccant, buffer and instruction for use

 

The Dengue NS1 Rapid Test Device (Whole blood/Serum/Plasma) can offer several healthcare benefits in the National Health Service (NHS) or any healthcare system. Here are potential benefits:

  1. Early Detection of Dengue Virus Infection: The rapid test allows for the early detection of Dengue virus NS1 antigen in whole blood, serum, or plasma, enabling timely diagnosis of Dengue fever.

  2. Prompt Medical Management: Early detection facilitates the prompt initiation of supportive medical care for individuals with Dengue fever, including fluid management to prevent dehydration and other symptomatic relief measures.

  3. Differentiation of Dengue from Other Febrile Illnesses: The NS1 antigen test aids in differentiating Dengue fever from other febrile illnesses, helping healthcare providers make accurate and targeted treatment decisions.

  4. Identification of Severe Cases: Detecting NS1 antigen can assist in identifying individuals at risk of developing severe Dengue, allowing for intensified monitoring and timely interventions to prevent complications.

  5. Resource Optimization: Rapid tests contribute to efficient resource utilization by providing quick and cost-effective diagnostic information, allowing healthcare providers to prioritize and manage Dengue cases more effectively.

  6. Point-of-Care Testing: Rapid tests can be performed at the point of care, providing quick results without the need for sending samples to a laboratory. This expedites decision-making, allowing for immediate medical management.

  7. Public Health Surveillance: Monitoring the prevalence of Dengue infections in the population through rapid testing contributes to public health surveillance efforts. This information helps in planning and implementing preventive measures, especially during outbreaks.

  8. Vector Control Strategies: Early detection of Dengue cases assists public health authorities in implementing vector control strategies to reduce the Aedes mosquito population and prevent further transmission of the virus.

  9. Travel Medicine: Rapid testing can be valuable for travelers returning from regions where Dengue is endemic, aiding in the early diagnosis of the infection and preventing potential transmission to others.

  10. Reduced Hospitalizations: Timely detection of Dengue virus infection may contribute to reducing the severity of illness, minimizing complications, and potentially decreasing the need for hospitalizations.

 

Infectious Disease Trials

Infectious disease trials are conducted to address various aspects related to the prevention, treatment, and understanding of diseases caused by infectious agents, such as bacteria, viruses, parasites, or fungi. Here are some reasons for conducting infectious disease trials:

  1. Vaccine Development: Trials are crucial for testing the safety and efficacy of new vaccines aimed at preventing infectious diseases. This includes vaccines for viruses like influenza, human papillomavirus (HPV), and emerging threats like COVID-19.
  2. Antiviral and Antibiotic Testing: Clinical trials assess the effectiveness of new antiviral medications or antibiotics in treating infections. This is particularly important in addressing antibiotic resistance and finding alternative treatments.
  3. Understanding Disease Mechanisms: Trials help researchers understand the mechanisms of infectious diseases, including how pathogens spread, evade the immune system, and cause illness.
  4. Global Health Concerns: Trials play a vital role in addressing global health concerns, such as emerging infectious diseases (e.g., Ebola, Zika, COVID-19) and ongoing challenges like malaria, tuberculosis, and HIV.
  5. Public Health Interventions: Trials evaluate the effectiveness of public health interventions, such as strategies for disease prevention, control, and containment.
  6. Drug and Treatment Development: Researchers conduct trials to develop and test new drugs or treatment regimens for infectious diseases, aiming to improve outcomes for affected individuals.
  7. Surveillance and Epidemiology: Clinical trials contribute to surveillance efforts by providing data on disease prevalence, transmission patterns, and the effectiveness of control measures.

Infectious disease trials are essential for advancing our understanding of these diseases, developing effective interventions, and ultimately improving global public health. They contribute significantly to the development of evidence-based strategies for preventing, treating, and managing infectious diseases.

 

Types of Infections

Types of Infections

 

For more information, contact us 01274 965089 or check out our website at www.nicheofficesolutions.co.uk www.nicheofficesolutions.co.uk/niche-nhs

Further clinical information can be found on our blog page: www.nicheofficesolutions.co.uk/category/niche-healthcare-news

For products not found on our online website, please view our Healthcare catalogues: www.nicheofficesolutions.co.uk/healthcare-catalogues

View our Healthcare YouTube videos Playlist

If you have any additional questions, drop us an email at info@nicheofficesolutions.co.uk 

Reviews

There are no reviews yet.

Be the first to review “Dengue NS1 Rapid Test Device”